Read More Pharma Industry News Genentech’s Lunsumio and Polivy combination triples remission in relapsed large B-cell lymphoma Genentech's chemo-free Lunsumio and Polivy combo tripled remission time in relapsed B-cell lymphoma, signaling a shift toward outpatient oncology treatment. byPallavi MadhirajuJune 25, 2025